Vivos Therapeutics (NASDAQ:VVOS) Stock Price Up 6.9% – What’s Next?

Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares rose 6.9% during mid-day trading on Friday . The stock traded as high as $5.12 and last traded at $4.98. Approximately 227,933 shares traded hands during trading, a decline of 50% from the average daily volume of 458,018 shares. The stock had previously closed at $4.66.

Analysts Set New Price Targets

A number of research analysts recently weighed in on VVOS shares. Alliance Global Partners decreased their price target on shares of Vivos Therapeutics from $8.25 to $6.00 and set a “buy” rating on the stock in a research note on Tuesday, November 19th. Ascendiant Capital Markets restated a “buy” rating and set a $6.60 price objective on shares of Vivos Therapeutics in a research report on Wednesday, November 20th.

Vivos Therapeutics Stock Up 6.9 %

The business’s 50-day simple moving average is $3.34 and its two-hundred day simple moving average is $2.81. The firm has a market capitalization of $24.08 million, a price-to-earnings ratio of -0.88 and a beta of 7.67.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.